Heather Preston - 07 Aug 2024 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Director
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Heather Preston
Issuer symbol
ALGS
Transactions as of
07 Aug 2024
Net transactions value
$0
Form type
4
Filing time
09 Aug 2024, 16:08:56 UTC
Previous filing
14 Jun 2023
Next filing
26 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 07 Aug 2024 Common Stock 120,000 $0.5500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares vest in thirty-six (36) successive and equal monthly installments measured from August 7, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.